Overview
What is Initiative For Medicines Access & Knowledge (I-Mak) Inc?
Initiative For Medicines Access & Knowledge (I-Mak) Inc is a nonprofit organization dedicated to establishing a fairer and more inclusive medicines system for everyone. They accomplish this through research, education, and collaborations, tackling structural disparities in the medicines system that influence who survives and who perishes, from drug creation to drug affordability. In 2021, I-Mak's public education initiative emphasized the crucial role of patents in the drug pricing debate. Furthermore, they testified in a congressional hearing on drug pricing and patent practices, resulting in substantial influence.
Official website here: www.i-mak.org
Is Initiative For Medicines Access & Knowledge (I-Mak) Inc legitimate?
Initiative For Medicines Access & Knowledge (I-Mak) Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Initiative For Medicines Access & Knowledge (I-Mak) Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $303,185
Professional Fundraising Fees: $0
Other Salaries and Wages: $216,049
For more financial information, click here
Official website here: www.i-mak.org
What is the mission statement of Initiative For Medicines Access & Knowledge (I-Mak) Inc?
The Initiative For Medicines Access & Knowledge (I-Mak) Inc is dedicated to establishing a fair and inclusive medicines system for all. Utilizing research, education, and collaborations, I-Mak works towards resolving structural inequalities in the medicines system, which impacts life and death, from drug development to affordability. In 2021, I-Mak's public education program highlighted the crucial role of patents in drug pricing discussions. Additionally, I-Mak testified in a hearing conducted by the House Committee on Oversight and Reform regarding drug pricing and patenting practices, leading to a notable impact.
Official website here: www.i-mak.org
Who is the CEO of Initiative For Medicines Access & Knowledge (I-Mak) Inc?
Tahir Amin is the Board Chair of Initiative For Medicines Access & Knowledge (I-Mak) Inc.
Official website here: www.i-mak.org
What is the revenue of Initiative For Medicines Access & Knowledge (I-Mak) Inc?
Initiative For Medicines Access & Knowledge (I-Mak) Inc's revenue in 2022 was $2,830,909.
Official website here: www.i-mak.org
Who are the executives of Initiative For Medicines Access & Knowledge (I-Mak) Inc and what are their salaries?
The average compensation at Initiative For Medicines Access & Knowledge (I-Mak) Inc during 2022 was $103,847. There are 5 employees and 7 volunteers at Initiative For Medicines Access & Knowledge (I-Mak) Inc.
Here are 9 key members and their salaries:
- Tahir Amin (Co-Founder/Co-Executive Director)
- Priti Krishtel (Co-Founder/Co-Executive Director)
- Lara Galinsky (Board Chair) [Trustee/Director]
- Renu Saini (Board Vice Chair) [Trustee/Director]
- Monica Mehta (Secretary) [Trustee/Director]
- Anne Lebleu (Treasurer (Thru Oct)) [Trustee/Director]
- Kayum Ahmed (Treasurer (Begin Sept)) [Trustee/Director]
- Scott Warren (Director)
- Patrick Ekeruo (Director)
Official website here: www.i-mak.org
Where can I find the form 990 for Initiative For Medicines Access & Knowledge (I-Mak) Inc?
The Initiative For Medicines Access & Knowledge (I-Mak) Inc’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.i-mak.org
Learn more at the official website: www.i-mak.org
Mission Statement of Initiative For Medicines Access & Knowledge (I-Mak) Inc
Initiative For Medicines Access & Knowledge (I-Mak) Inc is committed to establishing a more equitable and just medicines system for all. This nonprofit organization accomplishes this goal through a combination of research, education, and collaborative partnerships. I-Mak recognizes that the medicines system, encompassing drug development and affordability, significantly impacts who survives and who perishes. By addressing the structural inequalities within this system, I-Mak strives to bridge the gap and ensure fair access to essential medicines for everyone.
In 2021, I-Mak's public education initiative brought attention to the critical role of patents in drug pricing discussions. By making this issue the centerpiece of their efforts, I-Mak effectively contributed to the broader conversation about medicines affordability and patenting practices. Additionally, I-Mak testified before the House Committee on Oversight and Reform, providing valuable insights and expertise on drug pricing and patenting. These contributions resulted in a significant impact, further advancing I-Mak's mission to address the structural inequities within the medicines system.
Impact
This information is meant to be a general summary of Initiative For Medicines Access & Knowledge (I-Mak) Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
I-Mak's impact is significant in building a more just and equitable medicines system for all. Through research, education, and partnerships, I-Mak drives solutions to address the structural inequity in the medicines system that ultimately affects who lives and who dies. In 2021, I-Mak's public education program placed a spotlight on the pivotal role of patents in the drug pricing dialogue. Additionally, I-Mak provided crucial testimony in a house committee hearing on drug pricing and patenting practices, resulting in a significant influence.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
PROGRAM SERVICE REVENUE
Revenue
$33,811
Organization Details
Founding Year
2007
Phone
(917) 455-6601
Principal Officer
Tahir Amin
Main Address
16192 COASTAL HWY, LEWES, DE, 199583608
Website
www.i-mak.org
NTEE Category
Code: I83 - Crime
If you are a representative of Initiative For Medicines Access & Knowledge (I-Mak) Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.